BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17571101)

  • 1. [Can the screening of blood samples identify adverse drug reactions?].
    Buajordet I; Laake K; Brørs O
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1637-9. PubMed ID: 17571101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting adverse drug reactions on a geriatric ward: a pilot project.
    Somers A; Petrovic M; Robays H; Bogaert M
    Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active drug monitoring of adverse drug reactions in pediatric emergency department].
    Planchamp F; Nguyen KA; Vial T; Nasri S; Javouhey E; Gillet Y; Ranchin B; Villard F; Floret D; Cochat P; Gueyffier F; Kassaï B;
    Arch Pediatr; 2009 Feb; 16(2):106-11. PubMed ID: 19117738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
    Tribiño G; Maldonado C; Segura O; Díaz J
    Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU).
    Kane-Gill SL; Bellamy CJ; Verrico MM; Handler SM; Weber RJ
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1185-91. PubMed ID: 19728294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions (ADRs) in patients with previous history of chronic alcohol consumption without signs of chronic hepatic damage. A prospective study.
    Gonzáles-Martín G; Dominichinni H; Díaz M; Guevara A
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):20-6. PubMed ID: 7711986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study.
    González-Martin G; Caroca CM; Paris E
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):530-3. PubMed ID: 9799056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974-1993.
    Hunziker T; Bruppacher R; Kuenzi UP; Maibach R; Braunschweig S; Halter F; Hoigné RV
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):159-63. PubMed ID: 11998541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
    Nguyen JK; Fouts MM; Kotabe SE; Lo E
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):36-41. PubMed ID: 16730619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in hospitalized children in Fortaleza, Brazil.
    dos Santos DB; Coelho HL
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):635-40. PubMed ID: 16287200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of three methods of detecting adverse drug reactions.
    Berry LL; Segal R; Sherrin TP; Fudge KA
    Am J Hosp Pharm; 1988 Jul; 45(7):1534-9. PubMed ID: 3046347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
    Al-Malaq HM; Al-Aqeel SA; Al-Sultan MS
    Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.